Varigen

About:

Varigen Biosciences is developing new technologies for capturing and expressing natural product pathways.

Website: http://varigenbiosciences.com/

Twitter/X: varigen

Top Investors: National Science Foundation, Newchip Accelerator

Description:

Varigen Biosciences is developing new technologies for capturing and expressing natural product pathways. Learn about our DNAtrap™ custom cloning service which delivers verified clones of your DNA target (up to 100 kb) in just 10 days at http://varigenbiosciences.com/dnatrap-custom-cloning-service/. Learn about how our BigDNA™ metagenomics libraries can revolutionize natural product discovery at http://varigenbiosciences.com/products/.

Total Funding Amount:

$555000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Madison, Wisconsin, United States

Founded Date:

2016-01-01

Founders:

David Mead, Mark Liles

Number of Employees:

1-10

Last Funding Date:

2021-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai